Long et al.
FULL PAPER
1.00, CHCl3), m.p. 126—128 ℃; 1H NMR (CDCl3, 400
MHz) δ: 1.37 (s, 9H), 2.18 (s, 3H), 2.63—2.61 (m, 2H),
2.73—2.71 (m, 2H), 2.99 (t, J=4.8 Hz, 4H), 4.54 (d,
J=8.4 Hz, 1H), 4.99 (br s, 1H), 5.95 (dd, J=10.0, 4.4
Hz, 1H), 6.61 (d, J=10.0 Hz, 1H), 6.73 (d, J=8.8 Hz,
2H), 6.98 (d, J=8.4 Hz, 2H), 7.05—7.02 (m, 1H),
7.18—7.14 (m, 3H), 7.30 (d, J=6.4 Hz, 1H); 13C NMR
(CDCl3, 100 MHz) δ: 155.44, 149.57, 135.44, 129.87,
129.76, 129.04, 128.48, 128.33, 128.03, 126.96, 125.54,
116.66, 79.97, 64.05, 50.41, 48.86, 29.90, 28.67, 20.67;
IR (KBr) ν: 3346 (w), 2924 (s), 2850 (m), 1680 (s),
1560 (s), 1408 (s), 1365 (w), 1250 (w), 1174 (m), 1016
48.41, 29.86, 28.62, 18.00; IR (KBr) ν: 3344 (w), 3010
(m), 2974 (s), 2814 (m), 2350 (w), 1690 (s), 1585 (s),
1490 (s), 1330 (s), 1220 (s), 1174 (s),+1014 (s), 767 (m)
C26H33N3O2: C 74.43, H 7.93, N 10.02; found C 74.40,
H 7.90, N 10.01.
-1
cm ; MS (ESI) m/z: 420.17 (M+1) . Anal. calcd for
(1S,2S)-{2-[4-(2-Anisyl)-piperazin-1-yl]-1,2-dihy-
dronaphthalen-1-yl}-carbamic acid tert-butyl ester
(2g) Following the general procedure, compound 2g
was obtained as a white crystal (82.8 mg, 95%) purified
by chromatography on silica gel. Rf=0.23 on silica gel
plate [V(diethyl ether)∶V(petroleum ether) (60—90 ℃)
=1∶ 2]. The ee was determined to be 70% using HPLC
analysis on a Chiralcel OD-H column, λ=254 nm. Re-
tention time in 2% isopropanol in hexane was 13.2 min
(major) and 16.5 min (minor) (Scheme 1). [α]D20
+
-1
(m), 650 (m) cm ; MS (ESI) m/z: 420.08 (M+1) .
Anal. calcd for C26H33N3O2: C 74.43, H 7.93, N 10.02;
found C 74.42, H 7.91, N 10.01.
(1S,2S)-{2-[4-(2-Fluorophenyl)-piperazin-1-yl]-1,2-
dihydronaphthalen-1-yl}-carbamic acid tert-butyl
ester (2e) Following the general procedure, compound
2e was obtained as a white crystal (37.3 mg, 44%) puri-
fied by chromatography on silica gel. Rf=0.19 on silica
gel plate [V(diethyl ether)∶V(petroleum ether) (60—90
℃)=1∶2]. The ee was determined to be 33% using
HPLC analysis on a Chiralcel OD-H column, λ=254
nm. Retention time in 2% isopropanol in hexane was
8.7 min (major) and 11.8 min (minor). [α]2D0 -13.3 (c
1.00, CHCl3), m.p. 138—140 ℃; 1H NMR (CDCl3, 400
MHz) δ: 1.38 (s, 9H), 2.53—2.48 (m, 2H), 2.74—2.72
(m, 2H), 2.98—2.93 (m, 4H), 4.54 (d, J=6.8 Hz, 1H),
5.00 (br s, 1H), 5.96 (dd, J=10.0, 4.8 Hz, 1H), 6.61 (d,
J=10.0 Hz, 1H), 6.97—6.95 (m, 4H), 7.06—7.04 (m,
1H), 7.20—7.16 (m, 3H), 7.31 (d, J=6.0 Hz, 1H); 13C
NMR (CDCl3, 100 MHz) δ: 155.47, 149.52, 135.51,
129.80, 129.72, 129.10, 128.50, 128.31, 128.02, 126.94,
125.52, 116.63, 79.97, 64.04, 61.90, 50.40, 48.84, 28.64.
IR (KBr) νmax: 3346 (w), 3064 (m), 2954 (s), 2870 (m),
2360 (w), 1680 (s), 1502 (s), 1450 (s), 1365 (s), 1236 (s),
1
-160.5 (c 1.00, CHCl3), m.p. 193—194 ℃; H NMR
(CDCl3, 400 MHz) δ: 1.38 (s, 9H), 2.65 (br s, 2H),
2.77—2.75 (m, 2H), 2.94 (d, J=11.2 Hz, 4H), 3.75 (s,
3H), 4.55 (d, J=8.0 Hz, 1H), 5.03—5.01 (br s, 1H),
5.96 (dd, J=9.6, 4.4 Hz, 1H), 6.61 (d, J=10.0 Hz, 1H),
6.81—6.74 (m, 3H), 6.91—6.87 (m, 1H), 7.04—7.02
(m, 1H), 7.18—7.15 (m, 3H), 7.30 (d, J=7.2 Hz, 1H);
13C NMR (CDCl3, 100 MHz) δ: 155.69, 152.68, 141.92,
135.73, 132.89, 130.08, 128.69, 128.57, 128.53, 127.21,
125.92, 123.26, 121.38, 118.64, 110.47, 79.97, 64.34,
55.74, 51.58, 49.26, 48.88, 28.97; IR (KBr) ν: 3344 (w),
3062 (m), 2972 (s), 2816 (m), 2360 (w), 1690 (s), 1525
(s), 144-8 (s), 1367 (s), 1248 (s), 1172 (s),+1028 (s), 752
1
(m) cm . MS (ESI) m/z: 436.15 (M+1) . Anal. calcd
for C26H33N3O3: C 71.70, H 7.64, N 9.65; found C 71.69,
H 7.73, N 9.64.
(1S,2S)-[2-(4-Phenylpiperazin-1-yl)-1,2-dihydron-
aphthalen-1-yl]-carbamic acid tert-butyl ester (2i)
Following the general procedure, compound 2i was ob-
tained as a white crystal (51.8 mg, 65%) purified by
chromatography on silica gel. Rf=0.27 on silica gel
plate [V(diethyl ether)∶V(petroleum ether) (60—90 ℃)
=1∶ 2]. The ee was determined to be 10% using HPLC
analysis on a Chiralcel OD-H column, λ=254 nm. Re-
tention time in 2% isopropanol in hexane was 12.9 min
(major) and 14.8 min (minor). [α]2D0 -10 (c 1.00,
-1
1170 (s), 1014 (s), 756 (m) cm ; MS (ESI) m/z: 424.11
(M+). Anal. calcd for C25H30FN3O2: C 70.90, H 7.14, N
9.92; found C 70.88, H 7.12, N 9.91.
(1S,2S)-[2-(4-o-Tolylpiperazin-1-yl)-1,2-dihydron-
aphthalen-1-yl]-carbamic acid tert-butyl ester (2f)
Following the general procedure, compound 2f was ob-
tained as a white crystal (42.8 mg, 51%) purified by
chromatography on silica gel. Rf=0.21 on silica gel
plate [V(diethyl ether)∶V(petroleum ether) (60—90 ℃)
=1∶ 2]. The ee was determined to be 39% using HPLC
analysis on a Chiralcel OD-H column, λ=254 nm. Re-
tention time in 2% isopropanol in hexane was 7.4 min
(major) and 9.8 min (minor). [α]2D0 -32.5 (c 1.00,
1
CHCl3), m.p. 156—158 ℃; H NMR (CDCl3, 400
MHz) δ: 1.38 (s, 9H), 2.64 (br s, 2H), 2.75—2.72 (m,
2H), 3.05 (t, J=5.2 Hz, 4H), 4.60 (d, J=7.6 Hz, 1H),
5.05 (br s, 1H), 6.02 (dd, J=9.6, 4.0 Hz, 1H), 6.68 (d,
J=10.0 Hz, 1H), 6.94—6.90 (m, 3H), 7.07 (d, J=6.0
Hz, 1H), 7.14—7.11 (m, 5H), 7.27 (d, J=7.2 Hz, 1H);
13C NMR (CDCl3, 100 MHz) δ: 155.44, 151.62, 135.36,
129.93, 129.56, 128.53, 128.38, 128.06, 127.27, 125.48,
119.79, 116.39, 116.31, 64.06, 79.97, 53.64, 49.81,
48.86, 28.68, 28.30; IR (KBr) ν: 3439 (w), 3050 (m),
2951 (s), 2825 (m), 1608 (s), 1500 (s), 1450 (s), 1360
1
CHCl3), m.p. 168—170 ℃; H NMR (CDCl3, 400
MHz) δ: 1.39 (s, 9H) 2.18 (s, 3H), 2.49—2.46 (m, 2H),
2.60 (t, J=4.8 Hz, 2H), 2.78—2.76 (m, 4H), 4.55 (d,
J=8.0 Hz, 1H), 5.02 (br s, 1H), 5.97 (dd, J=9.6, 4.4
Hz, 1H), 6.61 (d, J=9.6 Hz, 1H), 6.93—6.90 (m, 2H),
7.08—7.02 (m, 3H), 7.19—7.16 (m, 3H), 7.33—7.31
(m, 1H); 13C NMR (CDCl3, 100 MHz) δ: 155.45,
152.00, 148.30, 135.48, 129.60, 129.07, 128.48, 128.29,
128.01, 126.92, 125.46, 118.61, 64.02, 79.97, 50.49,
-1
(s), 1242 (s), 1135 (s), 991 (s), 781(m) cm ; MS (ESI)
m/z: 406.09 (M+1)+. Anal. calcd for C25H31N3O2: C
74.04, H 7.70, N 10.36; found C 74.02, H 7.69, N 10.34.
(1S,2S)-{2-[4-(3,4-Dimethylphenyl)-piperazin-1-
yl]-1,2-dihydronaphthalen-1-yl}-carbamic acid tert-
240
© 2010 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2010, 28, 235— 242